Targeting neurodegenerative disease with a novel device
Longevity Technology - 19-Feb-2020Foundation of the new therapies mechanism is to access and control the compounds of CSF
EnClear Therapies
Device-based therapeutic solutions targeting neurodegenerative disease
At Enclear Therapies, our mission is to improve and extend the lives of genetically defined populations of patients suffering from neurodegenerative disease through the advancement of biomedical science and engineering to develop controlled access, delivery, and modification of cerebrospinal fluid.
Visit website: https://www.encleartherapies.com/
Details last updated 23-Feb-2020
EnClear Therapies News
People at EnClear Therapies
Anthony DePasqua
Strategic business leader with 20 years of demonstrated success in the medical device industry
